The Asian Scientist 100
Emi Ito
Institution
Osaka University
Country
Japan
Field
Life Sciences
Ito was awarded the 2023 JSPS Ikushi Prize by the Japan Society for the Promotion of Science for her research on unraveling the role of host-derived metabolites in the development of innate-type T cells.
(Photo: Osaka University)
AWARDS
- 2023 JSPS Ikushi Prize
Related articles
New AI Model Detects Methane Emissions From Space More Accurately
This will help in tracking and reducing methane emissions to fight climate change.
Scientists Find A New Clade Of Candida Auris, A Highly Transmissible Fungus
The study demonstrated that machine learning can improve surveillance by automatically detecting outlier genomes.
Cool Paint Can Make Urban Areas Feel 1.5°C Cooler
Applying cool paints to roofs, walls, and roads reduces heat absorption, making the built environment more comfortable for people
An Eye On AI
Backed by immense computing power, breakthroughs in AI are transforming multiple facets of society, from the way we deliver patient care to how we harness renewable energy resources like solar power.
Supporting Women In STEM
As part of a continuing effort to bridge the gender gap for women scientists, L’Oréal Singapore celebrated three outstanding women researchers in the L’Oréal-UNESCO For Women in Science 2023 program. Dr Leow Wan Ru, Dr Yang Le and Dr Xue Shifeng each received S$10,000 to advance their research.
The Oceans Are Running A Fever
Increasing marine heatwaves are breaking the resilience of aquatic life with long-term consequences for coastal communities.
Accelerating Advancements In Healthcare
From disease diagnostics to drug development, healthcare applications are poised to receive a major boost from the combined power of AI and supercomputing.
Dog Ownership Can Cut Dementia Risk By 40% In Older People
People with dogs tend to get into the habit of physical activity and forming social connections, which reduces their dementia risk.
How Estrogen Shields Tumors From The Immune System
The female sex hormone contributes to tumor progression in the estrogen-negative cancers lacking hormone receptors.









